Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
BioCircuit Technologies
company
About
BioCircuit Technologies develops noninvasive electrophysiology devices which monitor, control, and repair peripheral nerves.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $1.70M
- Industries
- Biotechnology,Health Care,Manufacturing,Medical,Medical Device
- Founded date
- Jan 1, 2016
- Number Of Employee
- 1 - 10
- Operating Status
- Active
BioCircuit Technologies develops noninvasive electrophysiology devices which monitor, control and repair peripheral nerves.BioCircuit’s products provide clinicians with a practical ability to diagnose health conditions earlier, track the progression of symptoms over time, and select treatments more precisely for individual patients.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$1.70M
BioCircuit Technologies has raised a total of
$1.70M
in funding over 2 rounds. Their latest funding was raised on
May 4, 2021 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 4, 2021 | Grant | $1.70M | 1 |
National Institutes of Health
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
BioCircuit Technologies is funded by 1 investors.
National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Institutes of Health
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
